Achieving Proof of Concept in Drug Discovery and Development (Record no. 348147)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01223nam a22001337a 4500 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 978-1-78536-938-4 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.45:346.58.061 |
| Item number | YU |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Yu, Helen |
| 245 ## - TITLE STATEMENT | |
| Title | Achieving Proof of Concept in Drug Discovery and Development |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc. | UK |
| Name of publisher, distributor, etc. | Edward Elgar |
| Date of publication, distribution, etc. | 2016 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | xiv,266p. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | PART I LANDSCAPE OF DRUG DISCOVERY AND DEVELOPMENT |
| -- | 1. Introduction |
| -- | 2. The pharmaceutical industry and drug discovery and development models |
| -- | 3. Intellectual property rights and competition law in collaborative drug discovery and development between industry and integrated drug discovery organizations |
| -- | PART II. ANALYSIS AND APPLICATION OF EU COMPETITION LAW TO THE INTEGRATED DRUG DISCOVERY AND DEVELOPMENT MODEL |
| -- | 4. Application of competition law to the integrated drug discovery and development model: research and development block exemption regulation |
| -- | 5. Application of competition law to the integrated drug discovery and development model: technology transfer block exemption regulation |
| -- | PART III. CASE STUDY: AGREEMENTS BETWEEN INDUSTRY AND INTEGRATED DRUG DISCOVERY ORGANIZATIONS |
| -- | 6. Analysis of collaboration agreements between integrated drug discovery organizations and industry |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Books |
No items available.